In recent years, because of the optimistic attitude about the development of IVD industry, various VC and PE investments are very active.

On December 19, at the 16th International Respiratory Symposium in Changshu, Abbott announced that it had joined the International Smart Health Alliance and signed an important strategic cooperation with the China Lung Cancer Prevention Alliance.

On December 18, 2020, Hipro biotechnology Corp announced the completion of the c-round financing of over 100 million YUAN.

CSRC has approved the registration of the initial public offering of Jiangsu HOB Biotech (HOB) Co., Ltd. on the science and technology innovation board.

Recently, TüV SüD Product Service GmbH an EU Notified Body certified the first IVDR CE certificate in the field of chemiluminescence in China, and its winner is Shenzhen New Industries Biomedical Engineering Co., Ltd.

On December 8, 2020, Beckman Coulter, Inc. and Realcan signed a strategic cooperation agreement in Shanghai and held a cooperation exchange meeting.

Maccura and Hoyotek Bio obtained the CE for their COVID-19 products.

Hann Pang, currently vice president of business operations in China, will take over as the president of Thermo Fisher China.

According to the info. released by NMPA, the certificate of the new type of medical equipment of 2019-nCov nucleic acid reagent kit (CRISPR with immunochromatography method) has been approved.

According to CBS News in the United States, due to the new crown epidemic or exposure, a total of about 1,500 Mayo Clinic health system staff are unable to work.

On November 25, 2020（Beijing time）, the US Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Innovita Biological ' novel coronavirus Innovita 2019-nCoV Ab Test (Colloidal gold).

Studies have shown that COVID-19 correlates with lymphopenia and low T cell concentrations, and mild COVID-19 correlates with a strong T cell response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

As one of the fastest growing segments of the in vitro diagnostics market, companion diagnostics is expected that its share in the in vitro diagnostics market will reach 14% in 2021.

In the first three quarters, net profit soared by 107 times, realizing a net profit of 2.013 billion yuan. Sansure Biotech: cash dividend is here!

In November 2020, three in-vitro diagnostic-related companies, AVE Science & Technology Industry Co., Ltd , Assure Tech (Hangzhou) Co., Ltd, and Novogene, had the first launch of the sci-tech innovation board.